The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Hypertension: Conducting Studies of Drugs to Treat Patients on a Background of Multiple Antihypertensive Drugs.'' This draft guidance is intended to clarify the recommended approach for sponsors developing drugs to treat hypertension for patients who are on a background of multiple antihypertensive drugs.
Document
Hypertension: Conducting Studies of Drugs To Treat Patients on a Background of Multiple Antihypertensive Drugs; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Hypertension: Conducting Studies of Drugs to Treat Pa...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 32878
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Hypertension: Conducting Studies of Drugs To Treat Patients on a Background of Multiple Antihypertensive Drugs; Draft Guidance for Industry; Availability,” thefederalregister.org (July 16, 2018), https://thefederalregister.org/documents/2018-15092/hypertension-conducting-studies-of-drugs-to-treat-patients-on-a-background-of-multiple-antihypertensive-drugs-draft-guid.